| Results of a prospective study of positron emission tomography–directed management of residual nodal abnormalities in node‐positive head and neck cancer after definitive … SV Porceddu, DI Pryor, E Burmeister, BH Burmeister, MG Poulsen, ... Head & neck 33 (12), 1675-1682, 2011 | 191 | 2011 |
| Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer DI Pryor, SV Porceddu, BH Burmeister, A Guminski, DB Thomson, ... Radiotherapy and Oncology 90 (2), 172-176, 2009 | 140 | 2009 |
| Utility of 68Ga prostate specific membrane antigen – positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma S Siva, J Callahan, D Pryor, J Martin, N Lawrentschuk, MS Hofman Journal of Medical Imaging and Radiation Oncology 61 (3), 372-378, 2017 | 101 | 2017 |
| Circulating tumor cell detection in high-risk non-metastatic prostate cancer J Loh, L Jovanovic, M Lehman, A Capp, D Pryor, M Harris, C Nelson, ... Journal of cancer research and clinical oncology 140 (12), 2157-2162, 2014 | 72 | 2014 |
| TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney-FASTRACK II S Siva, B Chesson, M Bressel, D Pryor, B Higgs, HM Reynolds, ... BMC cancer 18 (1), 1030, 2018 | 68 | 2018 |
| Human papillomavirus status and p16INK4A expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia A Antonsson, RE Neale, S Boros, G Lampe, WB Coman, DI Pryor, ... Cancer epidemiology 39 (2), 174-181, 2015 | 64 | 2015 |
| Stereotactic spine radiosurgery: Review of safety and efficacy with respect to dose and fractionation M Huo, A Sahgal, D Pryor, K Redmond, S Lo, M Foote Surgical neurology international 8, 2017 | 59 | 2017 |
| Australasian gastrointestinal trials group (AGITG) and trans-tasman radiation oncology group (TROG) guidelines for pancreatic stereotactic body radiation therapy (SBRT) A Oar, M Lee, H Le, G Hruby, R Dalfsen, D Pryor, D Lee, J Chu, ... Practical radiation oncology 10 (3), e136-e146, 2020 | 52 | 2020 |
| Economic analysis of FDG‐PET–guided management of the neck after primary chemoradiotherapy for node‐positive head and neck squamous cell carcinoma DI Pryor, SV Porceddu, PA Scuffham, JA Whitty, PA Thomas, ... Head & neck 35 (9), 1287-1294, 2013 | 49 | 2013 |
| Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand radiation oncology Genito-urinary group H Lieng, AJ Hayden, DRH Christie, BJ Davis, TN Eade, L Emmett, T Holt, ... Radiotherapy and Oncology 129 (2), 377-386, 2018 | 46 | 2018 |
| Development of an international prostate cancer outcomes registry SM Evans, N Nag, D Roder, A Brooks, J L Millar, KL Moretti, D Pryor, ... Bju International 117, 60-67, 2016 | 40 | 2016 |
| The emerging era of personalized therapy in squamous cell carcinoma of the head and neck DI Pryor, B Solomon, SV Porceddu Asia‐Pacific Journal of Clinical Oncology 7 (3), 236-251, 2011 | 34 | 2011 |
| Phase 2 multicenter study of Gantry-Based stereotactic radiotherapy boost for intermediate and high risk prostate cancer (prometheus) D Pryor, M Sidhom, S Arumugam, J Bucci, S Gallagher, J Smart, M Grand, ... Frontiers in oncology 9, 217, 2019 | 33 | 2019 |
| Development of indicators to assess quality of care for prostate cancer N Nag, J Millar, ID Davis, S Costello, JB Duthie, S Mark, W Delprado, ... European urology focus 4 (1), 57-63, 2018 | 32 | 2018 |
| Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group H Lieng, A Kneebone, AJ Hayden, DRH Christie, BJ Davis, TN Eade, ... Radiotherapy and Oncology 140, 68-75, 2019 | 28 | 2019 |
| A contemporary, nationwide analysis of surgery and radiotherapy treatment for prostate cancer MJ Roberts, N Papa, M Perera, S Scott, PE Teloken, A Joshi, I Vela, ... BJU international 124, 31-36, 2019 | 27 | 2019 |
| Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy J Sjövall, B Chua, D Pryor, E Burmeister, MC Foote, B Panizza, ... Oral Oncology 51 (3), 260-266, 2015 | 26 | 2015 |
| Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium MD Shanker, HY Liu, YY Lee, KA Stuart, EE Powell, A Wigg, DI Pryor Journal of Gastroenterology and Hepatology, 2020 | 24 | 2020 |
| Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma–Initial Experience From an Australian Liver Cancer Service HY Liu, Y Lee, K McLean, D Leggett, P Hodgkinson, J Fawcett, R Mott, ... Clinical Oncology, 2020 | 22 | 2020 |
| Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases G Kothari, AV Louie, D Pryor, I Vela, SS Lo, BS Teh, S Siva Chin Clin Oncol 6 (Suppl 2), S17, 2017 | 21 | 2017 |
